Center for Neurosciences

Futó vizsgálatok

• Meghívásos bevonás

  Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic

  NCT07417774· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  NCT07225504· 3. fázis· Forrás

• Meghívásos bevonás

  SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures

  NCT07141329· 2. fázis· Forrás

• Toboroz

  Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients

  NCT07051629· 1. fázis· Forrás

• Toboroz

  RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

  NCT06798896· 2. fázis· Forrás

• Fut, nem toboroz

  Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

  NCT06453213· 4. fázis· Forrás

• Toboroz

  Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

  NCT06510374· 3. fázis· Forrás

• Toboroz

  A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

  NCT06545955· 3. fázis· Forrás

• Meghívásos bevonás

  Long-term Safety and Tolerability of BHV-7000

  NCT06443463· 2. fázis· Forrás

• Fut, nem toboroz

  A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

  NCT06132893· 2/3. fázis· Forrás

• Fut, nem toboroz

  Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)

  NCT05685004· 2/3. fázis· Forrás

• Fut, nem toboroz

  A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM

  NCT03862430· 2. fázis· Forrás

• Fut, nem toboroz

  A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

  NCT05399888· 2. fázis· Forrás

• Fut, nem toboroz

  Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

  NCT05147220· 3. fázis· Forrás

• Fut, nem toboroz

  A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

  NCT05026866· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

  NCT04616326· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

  NCT04437511· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

  NCT03432286· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer

  NCT02138734· 1/2. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Epilepszia4 toboroz
• Hólyagrák2 toboroz
• Glioblasztóma1 toboroz
• Sclerosis multiplex (SM)1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome

  NCT05163314· 3. fázis· Forrás

• Lezárult

  A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome

  NCT04938427· 3. fázis· Forrás

• Leállították

  A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

  NCT04241068· 3. fázis· Forrás